x

Search for a clinical trial

* (*) mandatory field

22 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

AUSTRIA

OBERÖSTERREICH
LINZ

AUSTRIA

SALZBURG
SALZBURG

Recruiting trial
Ongoing trial
MEMMAT: A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma - AT
Salzburger Landeskliniken (SALK) / Paracelsus Med. Privatuniversität (PMU)
Universitätsklinik für Kinder- und Jugendheilkunde

AUSTRIA

STEIERMARK
GRAZ

AUSTRIA

WIEN
WIEN

Recruiting trial
Ongoing trial
MEMMAT: A Phase II study of metronomic and targeted anti-angiogenesis therapy for children with recurrent/progressive medulloblastoma - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Neonatologie, Pädiatrische Intensivmedizin und Neuropädiatrie

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Phase 2 single-arm study of gemcitabine in combination with oxaliplatin in refractory and relapsed pediatric solid tumors - Terminated -
CLCC Institut Gustave Roussy
Département de cancérologie de l'enfant et de l'adolescent

FRANCE

ILE-DE-FRANCE
VILLEJUIF

Recruiting trial
Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years (Phase II)
CLCC Institut Gustave Roussy
Département de cancérologie de l'enfant et de l'adolescent #

GERMANY

Bayern
REGENSBURG

Ongoing trial
NOA-07: Multicentre pilot study for the therapy of Medulloblastoma of the adulthood (Phase II)
Klinik und Poliklinik für Neurologie der Universität Regensburg
Klinik und Poliklinik für Neurologie

GERMANY

Hamburg
HAMBURG

GERMANY

Nordrhein-Westfalen
ESSEN

UNITED KINGDOM

Greater Manchester
NOT YET IDENTIFIED - UK

Multinational clinical trial(s)